Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Enlivex Therapeutics Ltd (ENLV)

Enlivex Therapeutics Ltd (ENLV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Enlivex Therapeutics and Lantern Pharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ORLANDO, FLORIDA / ACCESS Newswire / October 3, 2025 / RedChip Companies will air interviews with Enlivex Therapeutics Ltd. (Nasdaq:ENLV) and Lantern Pharma, Inc. (Nasdaq:LTRN) on the RedChip Small Stocks,...

ENLV : 0.9913 (+0.12%)
LTRN : 3.38 (-2.31%)
Enlivex Therapeutics and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ORLANDO, FLORIDA / ACCESS Newswire / September 19, 2025 / RedChip Companies will air interviews with Enlivex Therapeutics Ltd. (Nasdaq:ENLV) and 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) on the RedChip...

ENLV : 0.9913 (+0.12%)
SXTP : 0.9100 (-22.22%)
Home Sales Stateside, Canada GDP Due Next Week

Monday U.S. Economic Lookahead New home sales (July) Featured Earnings PDD ...

NVDA : 190.17 (+1.77%)
BEKE : 16.85 (+0.60%)
FRO : 25.48 (+1.72%)
CRWD : 537.55 (+1.47%)
SNOW : 257.02 (+0.04%)
ADSK : 299.39 (+0.75%)
MDB : 352.61 (+0.42%)
OKTA : 83.94 (+0.21%)
HEI : 313.64 (-1.19%)
NSSC : 40.35 (-0.10%)
JKS : 27.04 (+2.74%)
ENLV : 0.9913 (+0.12%)
Enlivex Therapeutics and Foremost Clean Energy Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ORLANDO, FL / ACCESS Newswire / June 13, 2025 / RedChip Companies will air interviews with Enlivex Therapeutics (NASDAQ:ENLV) and Foremost Clean Energy (Nasdaq:FMST) on the RedChip Small Stocks, Big Moneyâ„¢...

ENLV : 0.9913 (+0.12%)
FMST : 2.26 (-7.20%)
FAT.CN : 3.1700 (-5.65%)
RedChip Announces Webinar to Teach Investors How to Use RedChat, a Revolutionary AI Chatbot for Small-Cap Stock Analysis

Unlock AI-powered insights for data-driven precision and real-time efficiency

ENLV : 0.9913 (+0.12%)
ASPI : 8.11 (+1.37%)
BFRG : 0.9998 (-0.02%)
NVA : 9.83 (+3.26%)
GRRR : 12.94 (+0.15%)
The Trump Effect: Crypto Diversification Accelerates Across Industries

Issued on behalf of Spearmint Resources Inc. VANCOUVER – USA News Group – With the upcoming inauguration of US President Re-Elect Donald Trump on the horizon, several businesses are diversifying...

MSTR : 199.75 (-4.22%)
TSLA : 404.35 (+0.59%)
ENLV : 0.9913 (+0.12%)
SPMTF : 0.1190 (-12.88%)
SPMT.CN : 0.0050 (-33.33%)
^BTCUSDT : 93,796.37 (-1.37%)
HOTH : 1.1900 (+0.85%)
^BTCUSD : 93,770.40 (-1.35%)
Enlivex Therapeutics and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ORLANDO, FL / ACCESSWIRE / January 10, 2025 / RedChip Companies will air interviews with Enlivex Therapeutics Ltd. (Nasdaq:ENLV) and bioAffinity Technologies, Inc. (Nasdaq:BIAF) on the RedChip Small Stocks,...

ENLV : 0.9913 (+0.12%)
BIAF : 1.8400 (-2.13%)
Enlivex Therapeutics Ltd. Receives Approval for Phase I Trial of Allocetraâ„¢ in TMJ Osteoarthritis Patients

Enlivex Therapeutics received authorization for a Phase I trial of Allocetraâ„¢ for TMJ osteoarthritis in Israel.Quiver AI SummaryEnlivex Therapeutics Ltd. has received approval from the Israeli Ministry...

ENLV : 0.9913 (+0.12%)
Join Enlivex Therapeutics' Exclusive Live Investor Webinar and Q&A Session on December 3

NESS ZIONA, ISRAEL / ACCESSWIRE / November 26, 2024 / Enlivex Therapeutics Ltd. (Nasdaq:ENLV)(the "Company"), a clinical-stage macrophage reprogramming immunotherapy company, is pleased to invite investors...

ENLV : 0.9913 (+0.12%)
Enlivex Therapeutics Ltd. Approves Purchase of Up to $1 Million in Bitcoin as Part of Cash Management Strategy

Enlivex Therapeutics plans to purchase $1 million in Bitcoin to diversify its treasury reserves amid increasing demand.Quiver AI SummaryEnlivex Therapeutics Ltd., a clinical-stage company focused on macrophage...

ENLV : 0.9913 (+0.12%)

Barchart Exclusives

The Market Just Pulled Back. Here Is How To Protect Gains And Reset Risk
Investors panic during pullbacks because they react to emotion instead of structure. This piece shows how to protect gains, reset risk, and turn volatility into opportunity. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar